|
| |
NEOTROFIN Pages on BioPortfolio:
A Glimmer of Hope for Neotrofin
31 May 2002 ... In late April, NeoTherapeutics (NASDAQ: NEOT) announced that Neotrofin did not benefit patients with Alzheimer disease and canceled ...
http://www.bioportfolio.com/news/btech_053102_1.htm...
|
BioPortfolio - NEOTROFIN
Neotrofin Not Efficacious In The Treatment of Alzheimer Disease ... Neotrofin is NeoTherapeutics' lead anti-neurodegenerative developmental agent. ...
http://www.bioportfolio.com/search/NEOTROFIN_.html...
|
BioPortfolio - NeoTherapeutics Incorporated
The Company's initial product candidate, NEOTROFIN(TM) (AIT-082, leteprinim potassium) and other compounds under development are based on the Company's ...
http://www.bioportfolio.com/biocorporate/7443-NeoTherapeutic...
|
BioPortfolio - www.Neotherapeutics
Even if Neotrofin can demonstrate clinical benefit, NeoTherapeutics faces ... Neotrofin is NeoTherapeutics' lead anti-neurodegenerative developmental agent.
...
http://www.bioportfolio.com/search/www.Neotherapeutics.html...
|
BioPortfolio - i-brain life science
BioPortfolio - i-brain life science BioPortfolio - NEOTROFIN BioPortfolio - life after spinal cord injury medical newspapers ... Results from other life . ...
http://www.bioportfolio.com/search/i-brain_life_science.html...
|
BioPortfolio - NeoTherapeutics Incorporated - Profile
NEOTROFIN(TM) (AIT-082, leteprinim potassium) and other compounds under development are based on. the Company's patented technology. ...
http://www.bioportfolio.com/biocorporate/7443-NeoTherapeutic...
|
BioPortfolio - neotherapeutics irvine, ca
NeoTherapeutics (Irvine, CA), for example, has a small molecule called Neotrofin , which crosses the blood–brain barrier to switch on genes for neuronal . ...
http://www.bioportfolio.com/search/neotherapeutics_irvine,_c...
|
BioPortfolio - NEOTHERAPEUTICS
In late April, NeoTherapeutics (NASDAQ: NEOT) announced that Neotrofin did not benefit ... Neotrofin (leteprinim, NeoTherapeutics; Figure 2). This . ...
http://www.bioportfolio.com/search/_NEOTHERAPEUTICS_.html...
|
BioPortfolio - @neotherapeutics.com fax
Even if Neotrofin can demonstrate clinical benefit, NeoTherapeutics faces a long road to .... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/search/@neotherapeutics.com__fax...
|
T A B L E O F C O N T E N T S
3 -. T A B L E O F C O N T E N T S. 0. Executive Summary ....................... ....................................................... 15 ...
http://www.bioportfolio.com/cgi-bin/acatalog/Alzheimer%20dis...
|
Results from other life science and pharmaceutical sites:
A Glimmer of Hope for Neotrofin
31 May 2002 ... In late April, NeoTherapeutics (NASDAQ: NEOT) announced that Neotrofin did not benefit patients with Alzheimer disease and canceled ...
http://www.bioportfolio.com/news/btech_053102_1.htm...
|
Neotrofin increases heme oxygenase-1 selectively i...[Brain Res ...
We examined the interaction of Neotrofin, a cognitive-enhancing and neuroprotective drug, with the heme oxygenase system. In adult rats, both a
single ...
http://www.ncbi.nlm.nih.gov/pubmed/12543450...
|
BioPortfolio - NeoTherapeutics Incorporated
The Company's initial product candidate, NEOTROFIN(TM) (AIT-082, leteprinim potassium) and other compounds under development are based on the Company's ...
http://www.bioportfolio.com/biocorporate/7443-NeoTherapeutic...
|
The effects of Neotrofin on septodentate sprouting...[Restor ...
RESULTS: We observed that Neotrofin elevated the AChE-label in the outer molecular ... CONCLUSIONS: Neotrofin appears to have exerted limited stimulatory
...
http://www.ncbi.nlm.nih.gov/pubmed/12237496...
|
BioPortfolio - NeoTherapeutics Incorporated - Profile
NEOTROFIN(TM) (AIT-082, leteprinim potassium) and other compounds under development are based on. the Company's patented technology. ...
http://www.bioportfolio.com/biocorporate/7443-NeoTherapeutic...
|
Neotrofin, a novel purine that induces NGF-depende...[Mol Cell ...
We report peripheral actions in rats of Neotrofin, a purine derivative of ... We detected no Neotrofin-induced increases in cutaneous NGF levels or in ...
http://www.ncbi.nlm.nih.gov/pubmed/14664808...
|
Regenerative medicine Box 2
NeoTherapeutics (Irvine, CA), for example, has a small molecule called Neotrofin , which crosses the blood–brain barrier to switch on genes for neuronal ...
http://www.nature.com/materials/news/features/010301/nbt0301...
|
Neotrofin is transported out of brain by a saturab...[Drug Metab ...
Neotrofin (AIT-082; leteprinim potassium) is transported out of brain by a saturable mechanism and in this study the mechanisms mediating this efflux were
...
http://www.ncbi.nlm.nih.gov/pubmed/11950780...
|
Society for Neuroscience - 31st Annual Meeting Alexandra Kibble ...
related to Neotrofin (AIT-082; Figure 1). NEO-339 improves. performance in learning acquisition and amnestic reversal. tasks in mice; increases
sensorimotor ...
http://www.biomedcentral.com/content/pdf/cd-435433.pdf...
|
Neotrofin, a novel purine that induces NGF-dependent nociceptive ...
We report peripheral actions in rats of Neotrofin, a purine derivative of therapeutic interest. Syst...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
|
